Stock Ticker

  • Loading stock data...

Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)

Boston, MA 10/14/2014 (wallstreetpr) – Dynavax Technologies Corporation (NASDAQ:DVAX) announced on 13th October that it had initiated phase 1/2 clinical trials of its drug candidate SD-101. The target drug is expected to treat “lymphoma.” The drug would be tested across multiple study centres and will be introduced into the patient intratumorally. The treatment would be […]

Investor’s Digest: Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX), Dynavax Technologies Corporation (NASDAQ:DVAX) and Avon Products, Inc.(NYSE:AVP)

Boston, MA 02/19/2014 (wallstreetpr) – Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) has proposed to the town of Clifton that the road connecting Copper Verde with Shannon Hill be named as John Decker Drive. When the council meeting was in progress on Feb 13, at the Clifton Town limits, the name of the ex-Mayor who tragically passed […]

Dynavax Technologies Corporation (NASDAQ:DVAX) shares decline by 43.32%

Boston, MA 06/11/2013 (wallstreetpr) – The shares of Dynavax Technologies Corporation (NASDAQ:DVAX) had declined by 43.32 percent to close at $1.40 per share for the end of last trading session on Monday. The shares of the company had been trading in the range of $1.38 to $1.84 per share during the day. This recent decline in […]

Affymax (NASDAQ:AFFY)’s fourth quarter results out – SVM, DVAX

Boston, MA 04/08/2013 (wallstreetpr) – Affymax (NASDAQ:AFFY) closed at $1.16 on Friday’s stock market, a drop by 0.01% from its previous close of $1.17. The company is a small cap, with a potential of 46.46M in revenues as reported yesterday. The earnings per share were -1.52, with a profit margin of -65.57% when NASDAQ closed. […]

Quest Diagnostics (NYSE:DGX) Announce Quarter Dividend and Cost Cut Plan – DGX, DVAX, PFE, JNJ, BMY

Quest Diagnostics Inc (NYSE:DGX) announced on Friday that it is surging its quarterly dividend by 76 percent to 30 cents per share. It will be paid on Jan. 28. The firm reported that it aims to cut costs by $500M in 2014. It will go out 2014 with a run-rate savings of $600M, increase from […]